1.
Zheng EJ, Valeri JA, Andrews IW, et al. Discovery of antibiotics that selectively kill metabolically dormant bacteria. Cell chemical biology. 2023. doi:10.1016/j.chembiol.2023.10.026.
1.
Krill-Burger M, Dempster JM, Borah AA, et al. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. Genome biology. 2023;24(1):192. doi:10.1186/s13059-023-03020-w.
1.
Doherty T, Yao Z, Khleifat AAL, et al. Artificial intelligence for dementia drug discovery and trials optimization. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2023. doi:10.1002/alz.13428.
1.
Trastulla L, Savino A, Beltrao P, et al. Highlights from the 1st European cancer dependency map symposium and workshop. FEBS letters. 2023. doi:10.1002/1873-3468.14699.
1.
Way G, Natoli T, Adeboye A, et al. Morphology and gene expression profiling provide complementary information for mapping cell state. Cell systems. 2022;13(11):911-923.e9. doi:10.1016/j.cels.2022.10.001.
1.
Fanning S, Haque A, Imberdis T, et al. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 2019;73(5):1001-1014.e8. doi:10.1016/j.molcel.2018.11.028.
1.
Yang T, Ottilie S, Istvan ES, et al. MalDA, Accelerating Malaria Drug Discovery. Trends Parasitol. 2021;37(6):493-507. doi:10.1016/j.pt.2021.01.009.
1.
Rees MG, Seashore-Ludlow B, Clemons PA. Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines. Methods Mol Biol. 2019;1888:233-254. doi:10.1007/978-1-4939-8891-4_14.
1.
Leifer BS, Doyle SK, Richters A, Evans HL, Koehler AN. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives. Methods Enzymol. 2018;610:191-218. doi:10.1016/bs.mie.2018.09.019.
1.
Singh G, Dahlin JL, Walters MA. Risk Management in Early Discovery Medicinal Chemistry. Methods Enzymol. 2018;610:1-25. doi:10.1016/bs.mie.2018.09.012.